Core One Labs’ (COOL.C) wholly-owned subsidiary Vocan Biotechnologies has initiated the design and engineering of a proprietary enzymatic production system for API-grade N,N-dimethyltryptamine, commonly known as DMT. DMT, also…
DMT
Algernon Pharmaceuticals (AGN.C) awarded the contract for the synthesis and manufacture of the psychoactive ingredient and finished product for its AP-188 DMT project to Canadian-based Dalton Pharma Services today,…
Algernon Pharmaceuticals (AGN.C) and Charles River Laboratories agreed to have the latter handle Algernon’s DMT pre-clinical studies for their stroke clinical research program today, according to a press release….
Algernon Pharmaceuticals (AGN.C) has established a clinical trial program to treat stroke that uses DMT, or (N-dimethyltryptamine) today, according to a press release. The company decided to take a…
The notion of magic mushroom market offering after the legalization of cannabis has been floated time and again since long before cannabis legalization was even on the table. It…
A few states in our neighbour to the south decided to offer psilocybin based therapies during the most recent spate of elections, prompting more potential for companies like Xphyto…
Numinus Wellness (NUMI.V) is the first company to receive the Health Canada nod to standardize the extraction of psilocybin from mushrooms. The Health Canada nod comes at the behest…